shakers, incubators, ultralow freezers.......
Thursday July 27, 6:42 pm Eastern Time
Company Press Release
SOURCE: Genencor International, Inc.
Genencor Prices Initial Public Offering at $18 Per
Share
PALO ALTO, Calif., July 27 /PRNewswire/ -- Genencor International, Inc. (Nasdaq: GCOR - news) announced today the
pricing of its initial public offering of 7,000,000 shares of its common stock at a price of $18 per share. Net proceeds from the
offering will be approximately $117 million upon closing. The offering is being led by Merrill Lynch & Co., Chase H&Q, Credit
Suisse First Boston and Salomon Smith Barney are co-managers. The underwriters will be granted a 30-day over-allotment
option to purchase up to 1,050,000 additional shares of common stock from the company at a price of $18 per share.
Genencor International develops genetically based biotechnology products for the health care, agriculture and the industrial
chemicals markets. Genencor has principal corporate offices in Palo Alto, Calif., Rochester, N.Y. and Leiden, the Netherlands. (snip)
***************************
Trickle down from the liquidity burst of 2000 is going to overwhelm manufacturers, IMO. NBSC's competitors will be looking for capacity. |
